Atrial defibrillation using transcutaneous radio-frequency pulse delivery

G Manoharan, JA Santos, NE Evans, JMCC Anderson, BJ Kidawi, JD Allen, AAJ Adgey

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

Atrial fibrillation (AF) is one of the most common sustained cardiac arrhythmias found. Its treatment requires the use of a synchronised electrical shock or drug therapy. This paper describes a new form of electrical defibrillator that employs a two-part, transdermal RF transformer to couple an on-off keyed 7.2 MHz pulse to an implanted, passive receiver; this, in turn, delivers a unipolar DC shock to the heart. Factors influencing the transformer's design are discussed and results from axial and lateral primary/secondary coil displacement trials presented. In animal studies, cardioversion was 100% successful with pulses of 100 V amplitude and 10 ms width. The implant is battery-free, which makes it an attractive and inexpensive alternative for the treatment of AF.
Original languageEnglish
Title of host publicationUnknown Host Publication
PublisherIEEE
Pages313-316
Number of pages4
DOIs
Publication statusPublished - Nov 2001
EventThe Seventh Australian and New Zealand Intelligent Information Systems Conference, ANZIIS - Perth, Australia
Duration: 1 Nov 2001 → …

Conference

ConferenceThe Seventh Australian and New Zealand Intelligent Information Systems Conference, ANZIIS
Period1/11/01 → …

Fingerprint Dive into the research topics of 'Atrial defibrillation using transcutaneous radio-frequency pulse delivery'. Together they form a unique fingerprint.

  • Cite this

    Manoharan, G., Santos, JA., Evans, NE., Anderson, JMCC., Kidawi, BJ., Allen, JD., & Adgey, AAJ. (2001). Atrial defibrillation using transcutaneous radio-frequency pulse delivery. In Unknown Host Publication (pp. 313-316). IEEE. https://doi.org/10.1109/ANZIIS.2001.974096